In patients with SCD, the use of low dose anticoagulation as an outpatient may lead to a
significant decrease in morbidity and as a result, decrease healthcare utilization and costs.
This study attempts to critically avoid admissions by reducing daily pain scores and pain
crisis as an outpatient by use of a novel oral anticoagulant.